| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Adjusted EPS | $2.49 (up 15.3% YoY) | $1.57 (up 0.6% YoY) | 37% deceleration quarter-over-quarter |
| Japan Sales Growth | 11.8% YoY | 15.7% YoY | +390 bps acceleration |
| Japan Underlying Earned Premiums | -1.2% YoY | -1.2% YoY | Flat decline, no improvement despite record sales |
| Japan Benefit Ratio | 39.3% (27.8% third sector) | 65% total | +2570 bps jump as actuarial unlock effect fades |
| Japan Pretax Margin | 52.2% | 31.3% | -2090 bps normalization from unlock |
| U.S. Net Earned Premiums | +2.5% YoY | +4% YoY | +150 bps acceleration |
| U.S. Benefit Ratio | 45.6% | 48.6% | +300 bps deterioration |
| U.S. Pretax Margin | 21.7% | 17.4% | -430 bps compression |
| Group Life/Disability Sales | 24% increase in Q3 | 11.3% for full year | Strong but decelerating growth |
| Network Dental Sales | 40% growth first 9 months | 48.8% for full year | +880 bps acceleration in Q4 |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.